Hydromorphone Mundipharma Retard 4 mg
Hydromorphone Mundipharma Retard 4 mg is a medicine authorised by Swissmedic under authorisation number 70347. The authorisation holder is Mundipharma Regulatory GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 18 July 2025 and the authorisation is valid without a time limit. ATC code N02AA03 places the medicine in the group Analgesics.
| Authorisation number | 70347 |
|---|---|
| Name | Hydromorphone Mundipharma Retard 4 mg |
| Full name | Hydromorphone Mundipharma Retard 4 mg, Retardkapseln |
| Authorisation holder | Mundipharma Regulatory GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N02AA03 |
| First authorisation | 18 July 2025 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Hydromorphone Mundipharma Retard 4 mg, Retardkapseln | A+ | 18 July 2025 |
| 2 | Hydromorphone Mundipharma Retard 8 mg, Retardkapseln | A+ | 18 July 2025 |
| 3 | Hydromorphone Mundipharma Retard 16 mg, Retardkapseln | A+ | 18 July 2025 |
| 4 | Hydromorphone Mundipharma Retard 24 mg, Retardkapseln | A+ | 18 July 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 2 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 3 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 4 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 5 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 6 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 7 | 30 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
| 8 | 60 | Kapsel(n) | N02AA03 | 01.01.3. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Hydromorphone Mundipharma Retard 4 mg authorised in Switzerland?
Yes. Hydromorphone Mundipharma Retard 4 mg is authorised by Swissmedic under authorisation number 70347, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Hydromorphone Mundipharma Retard 4 mg have?
Hydromorphone Mundipharma Retard 4 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Hydromorphone Mundipharma Retard 4 mg?
The authorisation holder is Mundipharma Regulatory GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.